GraphoLearn Reading Intervention for Dyslexia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a computer-based reading program called GraphoLearn, designed to help children with dyslexia improve their reading skills. Participants will use GraphoLearn at home, and researchers will compare their progress to those using a math game as a control. The study will assess whether the reading improvements persist by evaluating skills again after 12 weeks. Suitable candidates for this trial are children aged 6 to 10 who are part of the Healthy Brain Network and have been struggling with reading, but do not have significant vision, hearing, or other severe mental health issues. As an unphased trial, this study offers a unique opportunity for children to potentially enhance their reading skills with a novel program.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the GraphoLearn reading intervention is safe for children with reading disabilities?
Research has shown that GraphoLearn, a computer-based reading program, has helped children improve their reading skills in many studies. Children who used GraphoLearn for about 7.5 hours demonstrated significant progress in matching sounds with letters, a crucial reading skill.
These studies primarily assess GraphoLearn's effectiveness rather than its safety. However, as a software program, GraphoLearn is less likely to cause physical side effects compared to medication-based treatments. No reports of negative effects from using GraphoLearn have emerged. Children generally receive this type of program well because it offers fun learning activities instead of medical treatments or drugs.12345Why are researchers excited about this trial?
Researchers are excited about the GraphoLearn reading intervention for dyslexia because it's a game-changer in how we approach reading difficulties. Unlike traditional methods that might use repetitive exercises or one-size-fits-all approaches, GraphoLearn turns learning into an engaging computer game. This unique method allows children to match sounds to letters and words at their own pace, making the learning process personalized and interactive. Additionally, it tracks progress, offering insights that can tailor future lessons to each child's needs, potentially making it a more effective and enjoyable way to improve reading skills in kids with dyslexia.
What evidence suggests that the GraphoLearn reading intervention is effective for dyslexia?
Research shows that GraphoLearn, a treatment in this trial, is a digital learning tool that effectively helps children develop early reading skills. Several studies have found that GraphoLearn improves reading fluency and comprehension by allowing children to practice matching sounds with letters and words. This interactive method adapts to each child's needs, making it a flexible tool for those with reading challenges. In one study, young readers using GraphoLearn showed significant improvements in word recognition and reading speed. Overall, the program is designed to make reading practice both fun and effective for young learners.24567
Who Is on the Research Team?
Nicole Landi, PhD
Principal Investigator
University of Connecticut
Are You a Good Fit for This Trial?
This trial is for children aged 6 to 10 who are part of the Healthy Brain Network, have reading difficulties as shown by specific test scores, and can speak English natively. They must be able to use a keyboard or mouse and not have severe vision or hearing issues, certain psychiatric conditions like psychosis or major depression, nor moderate to severe autism.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week GraphoLearn reading intervention or an active math control
Retention
Participants' reading gains are assessed for stability during a retention period
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- GraphoLearn reading intervention
- Vektor math control intervention
GraphoLearn reading intervention is already approved in European Union, United States, Canada for the following indications:
- Reading disability
- Dyslexia
- Reading disability
- Dyslexia
- Reading disability
- Dyslexia
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Connecticut
Lead Sponsor
Haskins Laboratories
Collaborator
Child Mind Institute
Collaborator
Georgia State University
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator